HDGF and breast cancer: As shown in Fig. 6g, h, compared to siRNA control, erdafitinib can achieve stronger inhibitory effects after HDGF knockdown in SW780 and RT112 cells, suggesting that HDGF downregulation can sensitize BC cells to erdafitinib.